SF500 logo

SF500

South America, Santa Fe, Argentina, Rosario

Description

SF500 is a BioTech acceleration program and VC fund

Investor Profile

SF500 has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 100% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Pre Seed rounds (top funding stages).
  • Majority of deals are located in United Kingdom, Argentina.
  • Strong thematic focus on Biotechnology, Health Care, Artificial Intelligence (AI).
  • Led 1 rounds in the past year.

Stage Focus

  • Seed (50%)
  • Pre Seed (50%)

Country Focus

  • United Kingdom (50%)
  • Argentina (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Artificial Intelligence (Ai)
  • Bioinformatics
  • Biopharma
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SF500 frequently co-invest with?

Zentynel Frontier Investments
South America, Region Metropolitana, Chile, Santiago
Co-Investments: 1
TP
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by SF500?

PILL.AR

Córdoba, Cordoba, Argentina

PILL.AR is a biotechnology company that offers personalised medication for people.

BiotechnologyHealth CareMedicalPharmaceutical
Pre SeedNov 6, 2024
Amount Raised: $250,000
MultiplAI Health

London, England, United Kingdom

MultiplAI Health is a leveraging advances in genomics and artificial intelligence to develop universal remote screening.

Artificial Intelligence (AI)BioinformaticsBiopharmaBiotechnologyHealth Care
SeedMar 2, 2023
Amount Raised: $2,688,728